Applied Therapeutics Inc (APLT)
NASDAQ:APLT
Holding APLT?
Track your performance easily

Applied Therapeutics (APLT) Financial Statements

506 Followers

Applied Therapeutics Financial Overview

Applied Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.321; its P/E ratio is -6.88; Applied Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 144.00K$ 190.00K$ -667.00K--
Gross Profit$ 144.00K$ 190.00K$ -667.00K--
EBIT$ -20.44M$ -83.94M$ -37.68M$ -42.37M$ -29.58M
EBITDA$ -20.32M$ -83.43M$ -37.28M$ -41.86M$ -28.89M
Net Income Common Stockholders$ 2.90M$ -83.94M$ -37.68M$ -42.37M$ -59.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 122.20M$ 146.50M$ 49.90M$ 37.50M$ 35.60M
Total Assets$ 127.78M$ 151.23M$ 54.83M$ 45.20M$ 43.63M
Total Debt$ 215.00K$ 343.00K$ 467.00K$ 535.00K$ 656.00K
Net Debt$ -121.98M$ -146.16M$ -49.43M$ -36.97M$ -34.94M
Total Liabilities$ 55.39M$ 83.94M$ 71.98M$ 56.24M$ 47.98M
Stockholders Equity$ 72.42M$ 67.29M$ -17.15M$ -11.04M$ -4.30M
Cash Flow-
Free Cash Flow$ -22.59M$ -18.91M$ -17.00M$ -14.74M$ -16.48M
Operating Cash Flow$ -22.59M$ -18.91M$ -17.00M$ -14.74M$ -16.48M
Investing Cash Flow-----
Financing Cash Flow$ -1.69M$ 115.50M$ 29.45M$ 16.57M$ 29.15M
Currency in USD

Applied Therapeutics Earnings and Revenue History

Applied Therapeutics Debt to Assets

Applied Therapeutics Cash Flow

Applied Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis